Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function (2024) Eisenhauer N, Miano M, Naumann-Bartsch N, Leyh J, Dell'Orso G, Aigner M, Fecker G, et al. Journal article Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis (2024) Kaulen LD, Karschnia P, Doubrovinskaia S, Abramson JS, Martinez-Lage M, Shankar G, Choi BD, et al. Journal article Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors (2022) Gozzetti A, Guarnieri A, Zamagni E, Zakharova E, Coriu D, Bittrich M, Pika T, et al. Journal article Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial (2022) Terpos E, Dimopoulos MA, Boccadoro M, Delimpasi S, Beksac M, Katodritou E, Moreau P, et al. Journal article Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry (2021) Hernandez-Boluda JC, Pereira A, Kroeger N, Cornelissen JJ, Finke J, Beelen D, De Witte M, et al. Journal article Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression (2018) Jabbour E, Duell J, Yilmaz M, Khoury JD, Ravandi F, Jain N, Einsele H, et al. Journal article